Skip to main content

Table 3 Characteristics of the statin users by dosage (in simvastatin equivalents). Mean (SD) if not otherwise indicated n = 87

From: Association between statin use and physical performance in home-dwelling older patients receiving polypharmacy: cross-sectional study

Simvastatin equivalent dose

1st quartile

(10 – 30 mg), n = 28

2nd quartile

(31 – 40 mg), n = 22

3rd quartile

(41 – 80 mg), n = 23

4th quartile

(81 – 336 mg), n = 14

Age (years)

82.3 (6.4)

81.0 (5.8)

81.0 (6.7)

78.4 (6.6)

Female, n (%)

18 (64)

12 (55)

12 (52)

6 (43)

BMI (kg/m2) a

24.7 (4.9)

25.9 (5.7)

26.7 (5.7)

29.4 (5.6)

CIRS (0-56)

16.9 (4.0)

16.8 (4.8)

17.3 (4.3)

18.0 (3.8)

FIM (18-126)

111.4 (12.5)

111.4 (10.4)

114.3 (9.1)

108.6 (12.7)

CDR (0-18)

2.3 (3.6)

1.3 (2.2)

1.9 (2.7)

4.1 (4.9)

Grip strength (kg)

21.0 (9.6)

18.3 (6.9)

22.8 (7.4)

24.9 (7.9)

Grip strength indicating sarcopenia b, n (%)

12 (43)

17 (77)

11 (48)

4 (29)

SPPB (0-12)

4.2 (3.1)

3.9 (2.8)

5.4 (2.9)

6.1 (3.8)

SPPB ≤8, n (%)

24 (86)

21 (96)

21 (91)

9 (64)

Gait speed (m/s) c

0.65 (0.20)

0.58 (0.19)

0.65 (0.16)

0.71 (0.22)

Gait speed ≤0.8 m/s, n (%)

18 (72)

17 (85)

18 (82)

7 (54)

  1. an = 83. Four missing due to height not reported
  2. b < 27 kg for men, < 16 kg for women
  3. cn = 80. Seven missing due to amputation or hemiparesis
  4. CI Confidence Interval, BMI Body mass Index, CIRS Cumulative Illness Rating Scale, FIM Functional Independence Measure, CDR Clinical Dementia Rating Scale (Sum of Boxes), SPPB Short Physical Performance Battery